Therefore, although some scholars prefer to refer to uterine tumors bearing COL1A1–PDGFB fusion as dermatofibrosarcoma in the uterus (considering the morphologic and IHC similarity), the nomenclature of uterine sarcoma with COL1A1–PDGFB fusion seems more appropriate. This evidence concerns the gene COL1A1 and tumor of uterus.